Receptor-specific adhesion and clinical disease in Plasmodium falciparum.
about
Human malarial disease: a consequence of inflammatory cytokine releaseAntigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparumMolecular aspects of severe malariaAntigenic variation in Plasmodium falciparum: gene organization and regulation of the var multigene familyInhibition of endothelial activation: a new way to treat cerebral malaria?Surface co-expression of two different PfEMP1 antigens on single plasmodium falciparum-infected erythrocytes facilitates binding to ICAM1 and PECAM1Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrierThe Cysteine-Rich Interdomain Region from the Highly Variable Plasmodium falciparum Erythrocyte Membrane Protein-1 Exhibits a Conserved StructureThe role of PfEMP1 as targets of naturally acquired immunity to childhood malaria: prospects for a vaccineAngiotensin II Moderately Decreases Plasmodium Infection and Experimental Cerebral Malaria in MiceSequestration and Tissue Accumulation of Human Malaria Parasites: Can We Learn Anything from Rodent Models of Malaria?Proteomic and genetic analyses demonstrate that Plasmodium berghei blood stages export a large and diverse repertoire of proteinsHost erythrocyte environment influences the localization of exported protein 2, an essential component of the Plasmodium translocon.Variant Exported Blood-Stage Proteins Encoded by Plasmodium Multigene Families Are Expressed in Liver Stages Where They Are Exported into the Parasitophorous VacuoleRapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings.Automated counting for Plasmodium falciparum cytoadherence experiments.Clonal variants of Plasmodium falciparum exhibit a narrow range of rolling velocities to host receptor CD36 under dynamic flow conditions.Rational design of anticytoadherence inhibitors for Plasmodium falciparum based on the crystal structure of human intercellular adhesion molecule 1.Plasmodium falciparum uses gC1qR/HABP1/p32 as a receptor to bind to vascular endothelium and for platelet-mediated clumping.Parasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model.Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculatureContinued cytoadherence of Plasmodium falciparum infected red blood cells after antimalarial treatment.Fucosylated chondroitin sulfate inhibits Plasmodium falciparum cytoadhesion and merozoite invasion.Dynamics in the cytoadherence phenotypes of Plasmodium falciparum infected erythrocytes isolated during pregnancy.Age-related buildup of humoral immunity against epitopes for rosette formation and agglutination in African areas of malaria endemicity.Biological and biochemical characteristics of cytoadhesion of Plasmodium falciparum-infected erythrocytes to chondroitin-4-sulfate.Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case-control studySingle molecule and multiple bond characterization of catch bond associated cytoadhesion in malaria.Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome.CR1 Knops blood group alleles are not associated with severe malaria in the GambiaVirulence of malaria is associated with differential expression of Plasmodium falciparum var gene subgroups in a case-control study.High levels of Plasmodium falciparum rosetting in all clinical forms of severe malaria in African children.Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications.Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria.Association of severe malaria outcomes with platelet-mediated clumping and adhesion to a novel host receptor.Investigating the host binding signature on the Plasmodium falciparum PfEMP1 protein family.A microfluidic system to study cytoadhesion of Plasmodium falciparum infected erythrocytes to primary brain microvascularendothelial cellsEvidence of promiscuous endothelial binding by Plasmodium falciparum-infected erythrocytes.Differential binding of clonal variants of Plasmodium falciparum to allelic forms of intracellular adhesion molecule 1 determined by flow adhesion assay.Plasmodium falciparum rosette formation is uncommon in isolates from pregnant women.
P2860
Q21034098-85F7C429-4543-43A2-B0EA-A53E00BA7CAFQ24533320-7740264A-B562-40CC-BB60-FEEF11FCACA6Q24550715-2A9A05C3-D5DC-49B7-867C-1885475B18FFQ24672872-34135732-86CA-4F48-BA02-437189A3265AQ24814891-4605C640-19C7-4266-ADCA-063CE50ABB65Q27313623-DEF2E245-801E-462E-B858-2E51C063863BQ27322655-E4D7B3B6-D454-49DF-B2FF-51218BD8B5C1Q27651999-95D6AA33-9707-4D64-9083-523406225393Q28070246-86ACAC15-F668-4826-9B50-46EC4AEB9A96Q28548078-F710F303-29E9-4B06-B355-A04D38850A47Q29396069-1F98FF8E-50A2-4CBE-B790-CD5F466E3FD9Q30040949-B428AEC4-DA3B-4E70-87DE-3882A3E51CFEQ30043299-BEB901E3-352F-4960-9070-6FB3018A9751Q30047429-CD68AF87-B36C-4CB0-B50E-CD10EC5AB804Q30493763-C8A2087C-5595-4088-90C7-445A2A6B1E19Q30500236-CCDB6E6E-0D37-4229-8210-7504C1CE0AB7Q30557590-278FF9AB-D8A4-4DA9-A02B-09CE14E1935FQ33232476-88B3ADC1-A97F-4E6F-BD8F-C30CCF8B5490Q33301011-0B5C7801-84C2-4B80-8024-5849B1F145E2Q33335133-3B66A4AA-142E-425A-8285-4EA7F68CFF2DQ33600266-1EDB7EFC-1FC7-410D-BD67-DBA87D2D2DD6Q33621397-D258A747-0458-4D97-A68D-0A22B6B0A585Q33622909-FAE44DBC-E657-46AF-BF56-6D0E391B0315Q33721310-48BFC390-A902-44CB-8803-90467FEAE62DQ33765361-D5319BB6-05EE-482F-A889-9044F2A74A2CQ33766474-18372516-42F4-4243-BC25-6D7DC23A1BB1Q33829057-F59DC46B-BCA3-43F9-A819-06B9FE0C3449Q33829952-06029403-2B56-40CC-BC92-3E1B096EB6CBQ33842019-E2B8224C-B1E4-4758-987D-A1A6A089340FQ33849061-868CD93D-B22E-4BE0-8E47-C3BA5C561158Q33879876-2E3DC1C0-6352-4DAE-B3CB-68B207938DBCQ33881768-215458A0-165E-4578-8856-D95ED182077BQ33884983-302E243B-7A95-4A91-B0C0-663E2469A5BCQ33890328-92C8EE3B-B9DC-4C15-B4B4-7A96C278124AQ33894907-455824DE-8FE7-493C-943D-F48CE177ABA9Q33900642-CE942C3A-091A-400C-B9AE-0D4546FC7EF7Q33956986-BC9642E6-9478-47E9-9925-7F4B872B96F4Q33967171-A1CB2F06-D7A8-4AF7-8DE5-2ED09143D244Q34003061-BFAA8AE1-A9EF-4E57-906D-FE7216B5D7F8Q34003113-76CD679F-5488-441F-B746-FCA0BF42298F
P2860
Receptor-specific adhesion and clinical disease in Plasmodium falciparum.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Receptor-specific adhesion and clinical disease in Plasmodium falciparum.
@en
Receptor-specific adhesion and clinical disease in Plasmodium falciparum.
@nl
type
label
Receptor-specific adhesion and clinical disease in Plasmodium falciparum.
@en
Receptor-specific adhesion and clinical disease in Plasmodium falciparum.
@nl
prefLabel
Receptor-specific adhesion and clinical disease in Plasmodium falciparum.
@en
Receptor-specific adhesion and clinical disease in Plasmodium falciparum.
@nl
P2093
P1476
Receptor-specific adhesion and clinical disease in Plasmodium falciparum.
@en
P2093
P304
P407
P50
P577
1997-10-01T00:00:00Z